The two phosphosites of FOXO1 found in this study are important for follicular development, prevent GCs from apoptosis, and may be valuable for developing compounds that disrupt the phosphorylation of FOXO1 by DYRK1A, which could serve as a potential choice for cancer-related drug design. This evidence concerns the gene DYRK1A and cancer.